Cutaneous melanoma begets cutaneous melanoma
Continued skin surveillance is important for survivors of cutaneous melanoma (CM), indicate findings showing that this is the most common second primary cancer among persons with a first CM.
Diagnosis & Disease Information
Cancer risk doubles for organ-transplant recipients
Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have twice as great a risk for diverse infection-related and unrelated cancers.
Radioactive iodine use in thyroid cancer on the rise despite its risks
Although substantial uncertainty persists regarding how to use radioactive iodine for thyroid cancer, the proportion of patients receiving this treatment is increasing, a recent study has determined.
FDA Update
Updates on varenicline, oral bisphosphonate drugs, and zytiga from the Food and Drug Administration, and information from the AERS on select oncology drugs.
Celecoxib may be new weapon in fight against liver cancer
A cyclooxygenase-2 (COX-2) selective nonsteroidal anti-inflammatory drug (NSAID) usually prescribed to relieve arthritis pain appears to be an effective treatment for liver cancer.
PET scans show effectiveness of thyroid drug
Positron emission tomography (PET) can indicate how well a thyroid tumor is responding to treatment with vandetanib, an agent with an effect on many intracellular metabolic pathways.
Treated or untreated, common thyroid cancer unlikely to cause death
Patients with papillary thyroid cancer experience favorable outcomes regardless of receiving treatment or not, according to a study published in the Archives of Otolaryngology – Head & Neck Surgery (2010;136[5]:440-444).
On-site pathologists can help patients avoid repeat thyroid biopsies
Ultrasound-guided thyroid biopsies can be improved by having a pathologist on site during the procedure, according to a study presented at the Annual Meeting of the American Roentgen Ray Society.
- Loading...
Loading...
Loading... 
Loading...